KRAS and cancer: Such endogenous TRAIL-dependent TRAIL-R2-mediated activation of the Rac1/PI3K/AKT pathway has been shown to promote migration, invasion and metastasis of KRAS-mutated cancer cells (von Karstedt et al., 2015).